REFERENCES
- Paling AJ, Viersma JH. Blunt trauma of the common femoral artery. J Pediatr Surg. 1999;34:1557–1558.
- Orrico C, Pasquinelli G, Foroni L, et al. Dysfunctional vasa vasorum in diabetic peripheral artery tructive disease with critical lower limb ischaemia. Eur J Vasc Endovasc Surg. 2010;40:365–374.
- Percival TJ, White JM, Ricci MA. Compartment syndrome in the setting of vascular injury. Perspect Vasc Surg Endovasc Ther. 2011;23:119–124.
- Forman MB, Virmani R, Puett DW. Mechanisms and therapy of myocardial reperfusion injury. Circulation. 1990;81(3 Suppl):IV69–78.
- Dick F, Li J, Giraud MN, et al. Basic control of reperfusion effectively protects against reperfusion injury in a realistic rodent model of acute limb ischemia. Circulation. 2008;118:1920–1928.
- Koksal C, BozKurt AK, Cangel U, et al. Attenuation of ischemia reperfusion injury by N-acetyl cysteine in a rat hind limb model. J Surg Res. 2003;111:236–239.
- Kearns SR, Daly AF, Sheehan K, et al. Oral vitamin C reduces the injury to skeletal muscle caused by compartimental syndrome. J Bone Joint Surg Br. 2004;86:906–911.
- Alves WF, Aguiar EE, Guimarães SB, et al. L-alanyl-glutamine preoperative infusion in patients with critical limb ischemia subjected to distal revascularization reduces tissue damage and protects from oxidative stress. Ann Vasc Surg. 2010;24:461–467.
- Wang WZ, Fang XH, Stephenson LL, et al. Melatonin attenuates I/R-induced mitochondrial dysfunction in skeletal muscle. J Surg Res. 2011;171:108–113.
- Gross ER, Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res. 2006;70:212–221.
- Yang XM, Krieg T, Cui L, et al. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through P13K, ERK and NO. J Moll Cell Cardiol. 2004;36:411–421.
- Ryan JW. Processing of the endogenous polypeptides by the lung. Annu Rev Physiol. 1982;44:241–255.
- Linz W. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25–49.
- Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;31:1–16.
- Regoli D. Kinins. Br Med Bull. 1987;43:270–284.
- Regoli D, Allogho SN, Rizzi A, et al. Bradykinin receptors and their antagonists. Eur J Pharmacol. 1998;348:1–10.
- Leeb-Lundberg LM, Marceau F, Müller-Esterl W, et al. International Union of Pharmacology. XLV Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57:27–77.
- Shigematsu S, Ishida S, Gute DC, et al. Concentration-dependent effects of bradykinin on leukocyte recruitment and venular hemodynamics in rat mesentery. Am J Physiol Heart Circ Physiol. 1999;277: H152–160.
- Souza DG, Pinho V, Pesquero JL, et al. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. Br J Pharmacol. 2003;139:129–139.
- Freise H, Palmes D, Spiegel H-U. Inhibition os angiotensin-converting enzime reduces rat liver reperfusion injury via bradykinin-2-receptor. J Surg Res. 2006;134:231–237.
- Nowak K, Weih S, Post S, et al. Bradykinin in ischemia–reperfusion injury of the lung. J Physiol Pharmacol. 2007;58 Suppl5(pt 2): 513–522.
- Kobara M, Tatsumi T, Kambayashi D, et al. Effects of ACE inhibition on myocardial apoptosis in an ischemia–reperfusion rat heart model. J Cardiovasc Pharmacol. 2003;41:880–889.
- Pan HL, Chen SR, Scicli GM, et al. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2000;279: H116–121.
- Strock PE, Majno G. Vascular responses to experimental tourniquet ischemia. Surg Gynecol Obstet. 1969;129:309–318.
- Tran TP, Tu H, Pipinos II, et al. Tourniquet-induced acute ischemia–reperfusion injury in mouse skeletal muscles: involvement of superoxide. Eur J Pharmacol. 2010;650:328–334.
- Henry JR, Chiamori N, Golub OJ. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutmic-pyruvic transaminase and lactic acid dehydrogensae. Am J Clin Pathol. 1960;34:381–398.
- Keiding R, Horder M, Gerhardt W. Recommended methods for determination of four enzymes in blood. Scand J Clin Lab Incest 1974;33:291–306.
- Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967;69:696–705.
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358.
- Nakamuta M, Ohashi M, Tanabe Y, et al. High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism. Hepatology. 1993;18:1377–1383.
- Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493–501,
- Schall R. Estimation in generalized linear models with random effects. Biometrika. 1991;78(4): 719–727.
- Brandão MD, Roselino JES, Piccinato CE. Mithochondrial alterations in skeletal muscle submitted to total ischemia. J Surg Res. 2003;110:235–240
- Piccinato CE, Roselino JES, Massuda CA. Lack of chlorpromazine effect on skeletal muscle metabolism after ischemia and a short reperfusion period. Microsurgery. 2004;24:194–199.
- Eckert P, Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg. 1991;26:77–84.
- Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB. Ischemia/reperfusion injury. J Surg Res 2002;105: 248–258.
- Grisotto PC, Santos AC, Piccinato CE. Indicators of oxidative injury and alterations of cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res. 2000;92:1–6.
- Park JW, Kang JW, Jeon WJ, et al. Postconditioning protects skeletal muscle from ischemia-reperfusion injury. Microsurgery. 2010;30:223–229.
- Gute DC, Ishida T, Yarimizu K, et al. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem. 1998;179:169–187.
- Matthews SB, Campbell AK. Neutrophil activation after myocardial infarction. Lancet. 1984;2:756–757.
- van Wagensveld BA, van Gulik TM, Gelderblom HC, et al. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann Surg. 1999;229:376–384.
- Zengyong Q, Jiangwei M, Huajin L. Effect of ligusticum wallichii aqueous extract on oxidative injury and immunity activity in myocardial ischemic reperfusion rats. Int J Mol Sci. 2011;12:1991–2006.
- Badhwar A, Forbes TL, Lovell MB, et al. Chronic lower extremity ischemia: a human model of ischemic tolerance. Can J Surg. 2004;47:352–358.
- Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem. 1980;26:1241–1250.
- Eliason JL, Wakefield TW. Metabolic consequences of acute limb ischemia and their clinical implications. Semin Vasc Surg. 2009;22:29–33.
- Vanlangenakker N, Vanden Berghe T, Krysko DV, et al. Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med. 2008;8:207–220.
- Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J. 1992;6:2450–2455.